Maryland Matters
September 26, 2026
Op-Ed by Vincent DeMarco
Excerpt:
“…Polling in Maryland and nationally show strong support for doing more to rein in drug costs. A 2025 poll, for example, showed that two-thirds of respondents nationwide support having Medicare negotiate prices for all drugs it purchases.
The General Assembly will consider legislation next year to give the board the authority to set drug upper payment limits for Marylanders that match the limits set by the federal Medicare program. This will create new savings for Marylanders as their health plans pay less for medications. Again, there is no reason to think this will lead to drug shortages in Maryland pharmacies.
Big Pharma continues to reap enormous profits at the expense of average Americans, while trying to confuse the public about the issue. According to a recent report by Public Citizen, the top 10 drug corporations in 2022 spent many billions more on advertising and profit-making activities than on research.”
Read the full op-ed at MarylandMatters.org.
Last modified: September 29, 2026
